Halozyme Therapeutics HALO
NASDAQ HALO
$109.86 +2.92 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Invested Capital (2012 - 2026)

Updated

Halozyme Therapeutics' Invested Capital came in at $2.29 billion for Q2 2026, up 24.3% from $1.84 billion a year earlier but down 3.1% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Invested Capital (2012 - 2026) Analysis & Trends

For FY2025, Halozyme Therapeutics' Invested Capital was $2.19 billion, up 17.2% from FY2024.

  • Invested Capital carries a five-year compound annual growth rate of 31.9% (FY2020 to FY2025).
  • Going back by year, Invested Capital was $1.87 billion in FY2024 (+18.1%), $1.58 billion in FY2023 (-5.5%), $1.68 billion in FY2022 (+56.1%) and $1.07 billion in FY2021 (+95.8%).
  • The five-year range for quarterly Invested Capital is $349.8 million (Q1 2022) to $2.36 billion (Q1 2026).
  • Year-over-year, Invested Capital has increased for ten consecutive quarters, with growth averaging 14.3% over the last eight quarters.
  • The fastest year-over-year change in Invested Capital over five years came in Q1 2023 (growth of 346.0%), and the weakest in Q4 2023 (a decline of 5.5%).
  • Business Quant data shows HALO's Invested Capital at $2.36 billion (Q1 2026), $2.19 billion (Q4 2025) and $2.01 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 134.01 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 64.89 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 50.26 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 38.08 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 148.69 Bn
10 Halozyme Therapeutics 12.53 Bn 11.13 Bn 401.83 Mn 2.29 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.29 Bn
Mar 31, 2026 2.36 Bn
Dec 31, 2025 2.19 Bn
Sep 30, 2025 2.01 Bn
Jun 30, 2025 1.84 Bn
Mar 31, 2025 1.99 Bn
Dec 31, 2024 1.87 Bn
Sep 30, 2024 1.96 Bn
Jun 30, 2024 1.79 Bn
Mar 31, 2024 1.68 Bn
Dec 31, 2023 1.58 Bn
Sep 30, 2023 1.75 Bn
Jun 30, 2023 1.65 Bn
Mar 31, 2023 1.56 Bn
Dec 31, 2022 1.68 Bn
Sep 30, 2022 1.60 Bn
Jun 30, 2022 392.22 Mn
Mar 31, 2022 349.80 Mn
Dec 31, 2021 1.07 Bn
Sep 30, 2021 370.93 Mn
API Access

Halozyme Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=HALO&period=max&api_key=YOUR_API_KEY